LATEST VERSION
DEVELOPING · 23 SEP → 26 SEP 2026 · 4 EDITIONS · 7 OUTLETS
FDA advisers endorse Grail’s multi-cancer blood test
How this story moved: how many newsrooms carried it at each run, when each one picked it up, how our summary's headline changed, and which figures and names held from the first reports to the latest. Everything here is counted from the coverage; none of it is a judgement of anyone's motives.
OUTLETS CARRYING THE STORY, RUN BY RUN
HOW OUR HEADLINE CHANGED · 3 HEADLINES
-
2026-09-23
FDA Panel to Decide on Approval of Grail's Multi-Cancer Blood Test
-
2026-09-24
Grail’s Multi-Cancer Blood Test Faces Key FDA Review
-
2026-09-24
FDA advisers endorse Grail’s multi-cancer blood test
WHAT HELD, WHAT CAME LATER
From the first reports to the latest
- Nothing ran from the first third of the coverage to the last.
Entered the story later
- Nothing new took hold after the first third.